Xianmin Feng
机构:Jilin Medical University · ORCID:0000-0002-5079-350X
发表论文 43 篇 · 总被引 496 次 · h-index 13
代表论文
- MOF nanoparticles with encapsulated dihydroartemisinin as a controlled drug delivery system for enhanced cancer therapy and mechanism analysis (2020 · Journal of Materials Chemistry B · 被引 81)
- A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity (2021 · Journal of Nanobiotechnology · 被引 56)
- Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression (2019 · Life Sciences · 被引 53)
- Isolation and genomic characterization of lymphocytic choriomeningitis virus in ticks from northeastern China (2018 · Transboundary and Emerging Diseases · 被引 47)
- Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis (2023 · Biomaterials Science · 被引 23)
- Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis (2020 · Journal of Materials Chemistry B · 被引 19)